Emmanuel B. Walter, MD, MPH

Related Content

Services

• Children's Primary Care

• Pediatrics / Primary Care Pediatrics
• Pediatrics / Infectious Diseases

Address:
DUMC 3675
Durham, NC 27710

Appointment Telephone:
(919) 620-5333

Office Telephone:
(919) 620-5374

Fax Telephone:
(919) 471-3820

• M.D., University of Maryland, 1983

• Pediatrics, University of Maryland, 1983-1986
• Pediatric Infectious Diseases, Duke University Medical Center, North Carolina, 1987-1990

• M.P.H., University of North Carolina at Chapel Hill, 1992

Clinical Interests:
General pediatrics, infectious diseases in children, vaccine research

Research Interests:
Dr. Emmanuel (Chip) B. Walter is Director of the Duke Translational Medicine Institute Clinical Vaccine Unit and he is Associate Director of the Primary Care Research Consortium at the Duke Clinical Research Institute.

Vaccine research:
  Clinical Trials (smallpox vaccines, pandemic and seasonal influenza virus vaccines, investigational respiratory virus vaccines, rotavirus vaccine, human papilloma virus vaccine,  conjugate pneumococcal vaccine, conjugate meningococcal vaccines, combination vaccines)

  Vaccine utilization (influenza vaccination of special populations, adolescent immunization)

Epidemiologic studies:
  National Children's Study

Representative Publications:
Walter EB, Royce RA, Fernández MI, DeHovitz J, Ickovics JR, Lampe MA, . New mothers' knowledge and attitudes about perinatal human immunodeficiency virus infection. Obstet Gynecol. 2001 Jan;97(1):70-6. (2001) Abstract

Walter EB, Hornick RB, Poland GA, Tucker R, Bland CL, Clements DA, Rhamstine CC, Jacobson RM, Brown L, Gress JO, Harris KE, Wiens BL, Nalin DR. Concurrent administration of inactivated hepatitis A vaccine with immune globulin in healthy adults. Vaccine. 1999 Mar 17;17(11-12):1468-73. (1999) Abstract

Clark HF, Burke CJ, Volkin DB, Offit P, Ward RL, Bresee JS, Dennehy P, Gooch WM, Malacaman E, Matson D, Walter E, Watson B, Krah DL, Dallas MJ, Schödel F, Kaplan M, Heaton P. Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation. Pediatr Infect Dis J. 2003 Oct;22(10):914-20. (2003) Abstract

Clements DA, Langdon L, Bland C, Walter E. Influenza A vaccine decreases the incidence of otitis media in 6- to 30-month-old children in day care. Arch Pediatr Adolesc Med. 1995 Oct;149(10):1113-7. (1995) Abstract

Englund JA, Walter EB, Fairchok MP, Monto AS, Neuzil KM. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children. Pediatrics. 2005 Apr;115(4):1039-47. (2005) Abstract

Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Pediatrics. 2006 Sep;118(3):e570-8. (2006) Abstract

Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Pediatrics. 2006 Sep;118(3):e579-85. (2006) Abstract

Guerra FA, Gress J, Werzberger A, Reisinger K, Walter E, Lakkis H, Grosso AD, Welebob C, Kuter BJ, . Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children. Pediatr Infect Dis J. 2006 Oct;25(10):912-9. (2006) Abstract